-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Lvr/GwEnEbePBneASs6yh9nI8NNxqEbPF7G+/miwF6J1fi1dDP8f4OCv4JPNlFR+ QZNhKfSvGWn2Yz7PbJeEhQ== 0001238925-06-000004.txt : 20061116 0001238925-06-000004.hdr.sgml : 20061116 20061116180155 ACCESSION NUMBER: 0001238925-06-000004 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20061116 FILED AS OF DATE: 20061116 DATE AS OF CHANGE: 20061116 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOSITE INC CENTRAL INDEX KEY: 0000834306 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 330288606 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11030 ROSELLE ST CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 6194554808 MAIL ADDRESS: STREET 1: 11030 ROSELLE ST CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: BIOSITE DIAGNOSTICS INC DATE OF NAME CHANGE: 19960710 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PADILLA NADINE E CENTRAL INDEX KEY: 0001238925 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-21873 FILM NUMBER: 061224417 BUSINESS ADDRESS: STREET 1: C/O BIOSITE INC STREET 2: 11030 ROSELLE STREET CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 8584554808 4 1 edgardoc.xml PRIMARY DOCUMENT X0202 4 2006-11-16 0 0000834306 BIOSITE INC BSTE 0001238925 PADILLA NADINE E BIOSITE INCORPORATED 9975 SUMMERS RIDGE ROAD SAN DIEGO CA 92121 0 1 0 1 Vice President, Investor Relat Vice President, Investor Relat Common Stock 2006-11-16 4 M 0 3750 10 A 6337 D Common Stock 2006-11-16 4 S 0 3750 49.11 D 2587 D Incentive Stock Option (right to buy) 10 2006-11-16 4 M 0 3750 49.11 D 1999-06-09 2009-06-09 Common Stock 3750 0 D Option vests daily over a four-year period commencing on the date of grant, except that no options are exercisable for the first six months after the date of grant. By: Robyn Shutak For: Nadine E. Padilla 2006-11-16 -----END PRIVACY-ENHANCED MESSAGE-----